Astellas ISR Portal - Welcome

New research proposal submissions for the following products, regionally, will be reviewed for consideration of support by Astellas.

Compound Region/Country
avacincaptad pegol
  • Saudi Arabia
  • United States
enfortumab vedotin
  • Asia (for country specific listing click here)
  • Australia
  • Europe (for country specific listing click here)
  • Middle East
  • United States (proposals will be reviewed jointly by Astellas and Pfizer)
enzalutamide
  • Asia (for country specific listing click here)
  • Australia
  • Canada
  • Europe (for country specific listing click here)
  • Japan
  • Latin America (for country specific listing click here)
  • Middle East and Africa (for country specific listing click here)
  • Russian Federation
  • Turkey
  • United States (proposals will be reviewed jointly by Astellas and Pfizer)
gilteritinib
  • Asia (for country specific listing click here)
  • Australia
  • Canada
  • Europe (for country specific listing click here)
  • Japan
  • Latin America (for country specific listing click here)
  • United Arab Emirates
fezolinetant
  • Australia
  • Brazil
  • Canada
  • Europe (for country specific listing click here)
  • Hong Kong
  • United States
mirabegron
  • Asia (for country specific listing click here)
  • Canada
  • Russia
ipragliflozin
  • Japan
roxadustat
  • Australia and Canada (for country specific listing click here)
  • Egypt
  • Japan
  • Russian Federation
  • Saudi Arabia
  • South Africa
  • Turkey
  • UAE
tacrolimus
  • China
  • Europe (for country specific listing click here)
  • Korea
zolbetuximab
  • Asia (for country specific listing click here)
  • Canada
  • Europe (for country specific listing click here)
  • Latin America (for country specific listing click here)
  • United States
Useful Hyperlinks

For investigators located in Europe, Israel, Canada:

In case your grant application is approved,a contract will be required.
Astellas will provide the contract that will contain several terms and conditions that are pre-defined.
You can find these pre-defined terms and conditions here.
Please be aware that this document is not the actual contract that will be proposed. Astellas does not have the capacity to re-negotiate these terms and conditions on a bespoke basis.
Therefore,prior to submitting your application, please verify within your institution that these terms and conditions are acceptable.

To view, click on the link below:

ISR AREAS OF INTEREST

For Japan products, please click here:

https://www.astellas.com/jp/isr/program/investigator-sponsored-research

Please do not use this website to report safety information or product complaints. To report safety information or product complaints about an Astellas medicine, please email according to region: For EMEA (Europe, Middle East and Africa): safety-EU@astellas.com ; for Americas (Canada, USA and Latin America): safety-US@astellas.com ; or for Asia/Oceania (Japan, Australasia): safety-JP@astellas.com.

Register Login